Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

LAMICTAL

SUPPORTING DATA

Marketing information
Key claims
Prevents depression
Does not destabilize mood
Supporting data
Improves quality of life
Tolerability similar to placebo
No weight gain
13 years of experience
A new approach
Introduce at any phase
Can be used in combination
Country information
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. Pivotal trial - index depressed* Authors: Calabrese JR, et al.; for the Lamictal 605 Study Group. Title: A placebo-controlled... 2. Pivotal trial - index manic* Authors: Bowden CL, et al.; for the Lamictal 606 Study group. Title: A placebo-controlled... 3. Lamotrigine for acute depression* Authors: Calabrese JR, et al. Title: A double-blind placebo-controlled study of lamotrigine... 4. Lamotrigine and lithium in bipolar disorder* Authors: Goodwin GM, et al. Title: A pooled analysis of two placebo-controlled 18-month trials... 5. Lamotrigine: open-label, 52-week trial* Authors: McElroy, et al. Title: A 52-week, open-label continuation study of Lamictal in the... 6. Lamotrigine safety review* Authors: Bowden CL, et al. Title: Safety and tolerability of lamotrigine for bipolar disorder.... 7. Lamotrigine does not destabilize mood* Authors: Grunze H, et al. Title: Lamotrigine controls bipolar depression without... 8. Lamotrigine: open longitudinal study on rapid cycling Authors: Walden J, et al. Title: An open longitudinal study of patients with bipolar rapid cycling... 9. Overview of lamotrigine clinical development Authors: Goldsmith DR, et al. Title: Lamotrigine, a review of its use in bipolar disorder....